"Receptors, Cytokine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell surface proteins that bind cytokines and trigger intracellular changes influencing the behavior of cells.
Descriptor ID |
D018121
|
MeSH Number(s) |
D12.776.543.750.705.852
|
Concept/Terms |
Receptors, Cytokine- Receptors, Cytokine
- Cytokine Receptors
- Cytokine Receptor
- Receptor, Cytokine
- Receptors, Cytokines
- Cytokines Receptors
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Cytokine".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Cytokine".
- Receptors, Cytokine
- Receptors, Chemokine
- Receptors, Colony-Stimulating Factor
- Receptors, Interferon
- Receptors, Interleukin
- Receptors, Oncostatin M
- Receptors, OSM-LIF
- Receptors, Thrombopoietin
- Receptors, Transforming Growth Factor beta
- Receptors, Tumor Necrosis Factor
This graph shows the total number of publications written about "Receptors, Cytokine" by people in this website by year, and whether "Receptors, Cytokine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1999 | 0 | 2 | 2 |
2002 | 0 | 1 | 1 |
2003 | 0 | 2 | 2 |
2004 | 1 | 1 | 2 |
2005 | 1 | 2 | 3 |
2007 | 0 | 1 | 1 |
2008 | 1 | 0 | 1 |
2009 | 0 | 2 | 2 |
2010 | 0 | 1 | 1 |
2011 | 0 | 1 | 1 |
2014 | 0 | 2 | 2 |
2019 | 0 | 1 | 1 |
2021 | 0 | 1 | 1 |
2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Cytokine" by people in Profiles.
-
Intermittent hypoxia inhibits epinephrine-induced transcriptional changes in human aortic endothelial cells. Sci Rep. 2022 10 13; 12(1):17167.
-
Pseudocell Tracer-A method for inferring dynamic trajectories using scRNAseq and its application to B cells undergoing immunoglobulin class switch recombination. PLoS Comput Biol. 2021 05; 17(5):e1008094.
-
A Threshold Model for T-Cell Activation in the Era of Checkpoint Blockade Immunotherapy. Front Immunol. 2019; 10:491.
-
Circulating microRNAs as Potential Biomarkers of Endothelial Dysfunction in Obese Children. Chest. 2016 Mar; 149(3):786-800.
-
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med. 2014 Sep 11; 371(11):1005-15.
-
The human carotid body releases acetylcholine, ATP and cytokines during hypoxia. Exp Physiol. 2014 Aug; 99(8):1089-98.
-
A role for IL-27 in limiting T regulatory cell populations. J Immunol. 2011 Jul 01; 187(1):266-73.
-
A role for IL-27p28 as an antagonist of gp130-mediated signaling. Nat Immunol. 2010 Dec; 11(12):1119-26.
-
Successful immunotherapy with IL-2/anti-CD40 induces the chemokine-mediated mitigation of an immunosuppressive tumor microenvironment. Proc Natl Acad Sci U S A. 2009 Nov 17; 106(46):19455-60.
-
Immunomodulators in asthma therapy. Curr Allergy Asthma Rep. 2009 Nov; 9(6):475-83.